FIELD: analytical measurements, pharmacy.
SUBSTANCE: method involves using a substance representing a pharmaceutically active component in a medicinal formulation characterized by sustained releasing preferably. Method involves carrying out the following procedures: (1) contacting a diluted nonaqueous composition containing analyzed substance and nonaqueous base, for example, wax or fat with an aqueous dissolving medium for predetermined time, and (ii) measurement of analyzed substance amount in aqueous dissolving medium. Invention provides enhancing precision and safety in assay of dissolving rate of analyzed substance.
EFFECT: improved assay method.
34 cl, 8 dwg, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITIONS CONTAINING MODIFIED CARRIER | 2003 |
|
RU2401127C2 |
| PHENYLEPHRINE RESINATE PARTICLES | 2014 |
|
RU2675788C2 |
| COATED PHENYLEPHRINE PARTICLES AND USE THEREOF IN PHARMACEUTICAL FORMULATIONS | 2014 |
|
RU2681312C2 |
| USE OF INVERSE AGONISTS OR ANTAGONISTS OF GHRELIN RECEPTOR FOR TREATING SLEEP DISORDERS | 2013 |
|
RU2600895C2 |
| SOLID PHARMACEUTICAL COMPOSITION (VERSIONS) AND METHOD FOR CONTROLLING GLUCOSE CONCENTRATION THEREWITH, METHOD FOR PREPARING SOLID PHARMACEUTICAL COMPOSITIONS (VERSIONS), TABLET (VERSIONS) AND METHOD FOR MAKING AMORPHOUS PARTICLES | 2008 |
|
RU2453332C2 |
| METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING DOWN SYNDROME | 2010 |
|
RU2549441C2 |
| COMPOSITION OF NANOSTRUCTURED APREPITANT, SYNTHESIS METHOD THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | 2011 |
|
RU2595841C2 |
| TABLET OF MELATONIN AND METHOD FOR PREPARING AND USING | 2008 |
|
RU2485949C2 |
| COMPOSITION FOR DELIVERING STABLE INJECTABLE LIQUIDS AND METHOD FOR DELIVERY | 2000 |
|
RU2259817C2 |
| RASAGILINE COMPOSITIONS WITH PROLONGED RELEASE AND USE THEREOF | 2011 |
|
RU2734632C2 |
